[{"NetIncomeLoss_2_Q2_USD":-18585000.0,"Liabilities_0_Q2_USD":51529000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-10000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-18000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"MarketableSecuritiesCurrent_0_Q2_USD":86935000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.0,"DeferredRentCreditCurrent_0_Q2_USD":117000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":5108000.0,"OperatingLeasesRentExpenseNet_2_Q2_USD":900000.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":400000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-134000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":20900000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":13076000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":6000.0,"AssetsCurrent_0_Q2_USD":135052000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":15948000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":9162000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":8667000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":16304000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1209000.0,"ShareBasedCompensation_2_Q2_USD":2920000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-45000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":25314000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-39000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":86935000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":1322000.0,"CommonStockSharesIssued_0_Q2_shares":27647234.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":213000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2785641.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":675000.0,"Assets_0_Q2_USD":140512000.0,"OperatingIncomeLoss_2_Q2_USD":-16375000.0,"OtherAssetsNoncurrent_0_Q2_USD":6000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-10713000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":219000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":10827000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":6295000.0,"EarningsPerShareBasic_2_Q2_USD":-0.68,"EarningsPerShareBasic_1_Q2_USD":-0.39,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-273000.0,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_Q2_USD":4353000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":27495125.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":27620764.0,"AssetsFairValueDisclosure_0_Q2_USD":102433000.0,"ProceedsFromStockPlans_2_Q2_USD":211000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-283000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":171000.0,"AccountsReceivableNetCurrent_0_Q2_USD":6271000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":1997000.0,"CommonStockValue_0_Q2_USD":505933000.0,"Revenues_1_Q2_USD":8171000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-18624000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":951000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":12100000.0,"IncreaseDecreaseInInventories_2_Q2_USD":1894000.0,"IncreaseDecreaseInDeferredCharges_2_Q2_USD":46000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":112200000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":938000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":58810000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":796000.0,"ForeignCurrencyTransactionGainLossUnrealized_2_Q2_USD":-314000.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":1300000.0,"ContractWithCustomerAssetNet_0_Q2_USD":0.0,"DepreciationDepletionAndAmortization_2_Q2_USD":896000.0,"Revenues_2_Q2_USD":15224000.0,"CommonStockNoParValue_0_Q2_USD":null,"AccruedProfessionalFeesCurrent_0_Q2_USD":1184000.0,"OperatingIncomeLoss_1_Q2_USD":-9868000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-10662000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-27000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-12866000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":6577000.0,"CommonStockDividendsPerShareCashPaid_2_Q2_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":27495125.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":27620764.0,"CostOfRevenue_2_Q2_USD":4824000.0,"CostOfRevenue_1_Q2_USD":2582000.0,"LiabilitiesCurrent_0_Q2_USD":15079000.0,"AccountsPayableCurrent_0_Q2_USD":2389000.0,"NonoperatingIncomeExpense_2_Q2_USD":-2200000.0,"NonoperatingIncomeExpense_1_Q2_USD":-794000.0,"InterestExpense_2_Q2_USD":1917000.0,"InterestExpense_1_Q2_USD":965000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":25814000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3525000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":585000.0,"NetIncomeLoss_1_Q2_USD":-10668000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":4954000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":70000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-29000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"PreferredStockNoParValue_0_Q2_USD":null,"GrossProfit_1_Q2_USD":5589000.0,"GrossProfit_2_Q2_USD":10400000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1548000.0,"LongTermDebtNoncurrent_0_Q2_USD":34921000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_2_Q2_USD":0.0,"NoncurrentAssets_0_Q2_USD":4954000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-18575000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q2_USD":2047000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":1948000.0,"InventoryNet_0_Q2_USD":13007000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":473000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":140512000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3692000.0,"PreferredStockSharesAuthorized_0_Q2_shares":25000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":2920000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1808000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":767000.0,"OperatingExpenses_2_Q2_USD":26775000.0,"OperatingExpenses_1_Q2_USD":15457000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":1990000.0,"ProfitLoss_2_Q2_USD":-18585000.0,"DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_0_Q2_USD":596000.0,"StockholdersEquity_0_Q2_USD":88983000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":273000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":35000000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":45461000.0,"RestrictedCashNoncurrent_0_Q2_USD":500000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.39,"EarningsPerShareDiluted_2_Q2_USD":-0.68,"CommonStockSharesOutstanding_0_Q2_shares":27647234.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-560000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":7000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":733000.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":10000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-416816000.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q2_USD":2098000.0,"DeferredRentCreditNoncurrent_0_Q2_USD":1529000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":500000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":86934000.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":6000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":13394000.0,"Ticker":"TMDX","CIK":"1756262","name":"TRANSMEDICS GROUP, INC.","OfficialName":"TransMedics Group Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"632779019.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]